| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 124.19B | 126.96B | 123.98B | 126.01B | 134.58B | 120.68B |
| Gross Profit | 47.10B | 48.37B | 46.55B | 45.99B | 48.99B | 45.71B |
| EBITDA | 11.47B | 11.03B | 11.63B | 12.94B | 16.44B | 16.20B |
| Net Income | 4.91B | 5.41B | 4.78B | 5.58B | 9.19B | 9.57B |
Balance Sheet | ||||||
| Total Assets | 112.99B | 119.63B | 113.96B | 108.72B | 109.03B | 91.71B |
| Cash, Cash Equivalents and Short-Term Investments | 11.72B | 13.03B | 12.30B | 12.98B | 12.88B | 8.16B |
| Total Debt | 28.71B | 30.44B | 30.08B | 26.23B | 28.17B | 21.02B |
| Total Liabilities | 53.08B | 54.70B | 52.69B | 54.23B | 61.55B | 54.23B |
| Stockholders Equity | 59.68B | 64.67B | 61.02B | 54.26B | 47.30B | 37.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.67B | -1.69B | 6.37B | -118.00M | 798.00M |
| Operating Cash Flow | 0.00 | 8.03B | 2.04B | 12.40B | 4.16B | 6.96B |
| Investing Cash Flow | 0.00 | -2.99B | -4.19B | -6.31B | -3.87B | -6.85B |
| Financing Cash Flow | 0.00 | -4.62B | 1.01B | -6.38B | 4.65B | -2.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥54.00B | 8.73 | ― | 3.94% | 2.40% | 15.35% | |
66 Neutral | ¥8.01B | 8.93 | ― | 3.96% | 6.05% | -67.41% | |
64 Neutral | ¥26.30B | 20.68 | ― | 1.85% | 4.87% | -5.52% | |
63 Neutral | ¥1.47T | 27.67 | 5.92% | 1.93% | 1.37% | -38.81% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥238.96B | 12.92 | ― | 1.51% | ― | ― | |
60 Neutral | ¥221.11B | 20.90 | 15.93% | 0.72% | 18.35% | 15.11% |